Citation Impact
Citing Papers
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
2016 Standout
Predicting Survival in Pulmonary Arterial Hypertension
2010 Standout
A sex-biased imbalance between Tfr, Tph, and atypical B cells determines antibody responses in COVID-19 patients
2023 StandoutNobel
Imatinib Mesylate as Add-on Therapy for Pulmonary Arterial Hypertension
2013
Cancer statistics, 2022
2022 Standout
Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging
2015 Standout
Prediction of Pulmonary Complications and Long‐Term Survival in Systemic Sclerosis
2014
Cancer statistics, 2023
2023 Standout
Graft microvascular disease in solid organ transplantation
2014 StandoutNobel
A RASSF1A-HIF1α loop drives Warburg effect in cancer and pulmonary hypertension
2019 StandoutNobel
British Thoracic Society guideline for diagnostic flexible bronchoscopy in adults: accredited by NICE
2013 Standout
Haemodynamic definitions and updated clinical classification of pulmonary hypertension
2018 Standout
Plasma Hsp90 levels in patients with systemic sclerosis and relation to lung and skin involvement: a cross-sectional and longitudinal study
2021 Standout
Cancer statistics, 2024
2024 Standout
Cancer Statistics, 2021
2021 Standout
Idiopathic pulmonary fibrosis
2017 Standout
Review: Hemodynamic Characteristics and Outcomes of Sickle Cell Disease Associated Pulmonary Hypertension
2016
Lung cancer staging: a concise update
2018
Pulmonary veno-occlusive disease
2016
Right Heart Assessment by Echocardiography: Gender and Body Size Matters
2012
Sleep as a New Target for Improving Outcomes in Idiopathic Pulmonary Fibrosis
2017
Role of Serial Quantitative Assessment of Right Ventricular Function by Strain in Pulmonary Arterial Hypertension
2012
Undiagnosed connective tissue diseases
2016
Doppler Myocardial Imaging for Early Detection of Right Ventricular Dysfunction in Patients With Pulmonary Hypertension
2008
Resistin-Like Molecule-β in Scleroderma-Associated Pulmonary Hypertension
2009
Prognostic factors of acute heart failure in patients with pulmonary arterial hypertension
2009
Hyponatremia and Mortality: Moving Beyond Associations
2013
Effects of oral treatments on exercise capacity in systemic sclerosis related pulmonary arterial hypertension: a meta-analysis of randomised controlled trials
2007
An official European Respiratory Society/American Thoracic Society research statement: interstitial pneumonia with autoimmune features
2015 Standout
Pediatric Pulmonary Hypertension
2013
Ambrisentan response in connective tissue disease-associated pulmonary arterial hypertension (CTD-PAH) – A subgroup analysis of the ARIES-E clinical trial
2016
Definitions and Diagnosis of Pulmonary Hypertension
2013 Standout
A USA-based registry for pulmonary arterial hypertension: 1982–2006
2007
Pulmonary Hypertension Due to Left Heart Diseases
2013
Macrophages in immunoregulation and therapeutics
2023 Standout
Updated Clinical Classification of Pulmonary Hypertension
2009 Standout
Pulmonary Hypertension in Chronic Lung Diseases
2013
Obesity and inflammation: the linking mechanism and the complications
2016 Standout
Systemic sclerosis
2017 Standout
Pulmonary hypertension in chronic lung disease and hypoxia
2018
Early detection of pulmonary arterial hypertension
2014
Management of Pulmonary Arterial Hypertension Associated with Congenital Systemic-to-Pulmonary Shunts and Eisenmenger???s Syndrome
2008
Changes in causes of death in systemic sclerosis, 1972–2002
2007 Standout
Schistosomiasis
2018 Standout
Interstitial lung disease guideline
2008
Impact of Comorbidities on Mortality in Patients with Idiopathic Pulmonary Fibrosis
2016
Clinical practice guideline on diagnosis and treatment of hyponatraemia
2014 Standout
Angiogenesis and Vasculopathy in Systemic Sclerosis: Evolving Concepts
2011
The impact of cardiopulmonary manifestations on the mortality of SSc: a systematic review and meta-analysis of observational studies
2012
The Society for Vascular Surgery practice guidelines on the care of patients with an abdominal aortic aneurysm
2017 Standout
Riociguat for the Treatment of Pulmonary Arterial Hypertension
2013
Diagnosis and Assessment of Pulmonary Arterial Hypertension
2009
Lung tissues in patients with systemic sclerosis have gene expression patterns unique to pulmonary fibrosis and pulmonary hypertension
2010
Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging
2015 Standout
Right ventricular systolic pressure by echocardiography as a predictor of pulmonary hypertension in idiopathic pulmonary fibrosis
2008
Idiopathic pulmonary fibrosis
2017 Standout
Updated Clinical Classification of Pulmonary Hypertension
2013 Standout
Obstructive Sleep Apnea Is Common in Idiopathic Pulmonary Fibrosis
2009
The Emerging Role of Magnetic Resonance Imaging in the Diagnosis and Management of Pulmonary Hypertension
2008
Clinician’s Guide to Cardiopulmonary Exercise Testing in Adults
2010 Standout
Effects of Iron Supplementation and Depletion on Hypoxic Pulmonary Hypertension
2009 StandoutNobel
Evaluation of cardiac abnormalities by Doppler echocardiography in a large nationwide multicentric cohort of patients with systemic sclerosis
2007
Riociguat for the treatment of pulmonary arterial hypertension associated with connective tissue disease: results from PATENT-1 and PATENT-2
2016
Accuracy of Doppler Echocardiography in the Hemodynamic Assessment of Pulmonary Hypertension
2009
A Novel Paradigm for Heart Failure With Preserved Ejection Fraction
2013 Standout
Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension
2015 Standout
Major lung complications of systemic sclerosis
2018
Deformation imaging describes right ventricular function better than longitudinal displacement of the tricuspid ring
2009
Idiopathic pulmonary fibrosis
2011 Standout
Guidelines for the Use of Echocardiography as a Monitor for Therapeutic Intervention in Adults: A Report from the American Society of Echocardiography
2015
The increase in pulmonary arterial pressure caused by hypoxia depends on iron status
2008 StandoutNobel
Autologous non-myeloablative haemopoietic stem-cell transplantation compared with pulse cyclophosphamide once per month for systemic sclerosis (ASSIST): an open-label, randomised phase 2 trial
2011
Pulmonary hypertension due to left heart disease
2018
Diagnosis and Treatment of Connective Tissue Disease-Associated Interstitial Lung Disease
2013
Systemic sclerosis
2015
Comorbidities in idiopathic pulmonary fibrosis patients: a systematic literature review
2015
Hypoxia-induced mitogenic factor (HIMF/FIZZ1/RELMα) in chronic hypoxia- and antigen-mediated pulmonary vascular remodeling
2013
Mining electronic health records: towards better research applications and clinical care
2012 Standout
Outcome of pulmonary endarterectomy in symptomatic chronic thromboembolic disease
2014
Guidelines for the Echocardiographic Assessment of the Right Heart in Adults: A Report from the American Society of Echocardiography
2010 Standout
Ferric carboxymaltose improves exercise capacity and quality of life in patients with pulmonary arterial hypertension and iron deficiency: A pilot study
2014
Schistosomiasis-Associated Pulmonary Hypertension
2010
Pulmonary hypertension in COPD
2008
Clinical Course and Prediction of Survival in Idiopathic Pulmonary Fibrosis
2010 Standout
A cross-sectional study of the prevalence and associations of iron deficiency in a cohort of patients with chronic obstructive pulmonary disease
2015 StandoutNobel
Benefits of Pulmonary Rehabilitation in Idiopathic Pulmonary Fibrosis
2011
Prognostic Value of Right Ventricular Longitudinal Peak Systolic Strain in Patients With Pulmonary Hypertension
2012
Nintedanib for Systemic Sclerosis–Associated Interstitial Lung Disease
2019 Standout
Characteristics and Outcome After Hospitalization for Acute Right Heart Failure in Patients With Pulmonary Arterial Hypertension
2011
The role of chemokines and chemokine receptors in pulmonary arterial hypertension
2019
Borderline pulmonary arterial pressure in systemic sclerosis patients: a post-hoc analysis of the DETECT study
2014
Clinical iron deficiency disturbs normal human responses to hypoxia
2016 StandoutNobel
Activation of hypoxia-inducible factor-1 in pulmonary arterial smooth muscle cells by endothelin-1
2013 StandoutNobel
Pulmonary Arterial Hypertension
2006
Management of Massive and Submassive Pulmonary Embolism, Iliofemoral Deep Vein Thrombosis, and Chronic Thromboembolic Pulmonary Hypertension
2011 Standout
Clinical Differences Between Idiopathic and Scleroderma-Related Pulmonary Hypertension
2007
Electromechanical and robot-assisted arm training for improving activities of daily living, arm function, and arm muscle strength after stroke
2015
Guidelines for Adult Stroke Rehabilitation and Recovery
2016 Standout
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
Effects of Phosphodiesterase Type 5 Inhibition on Systemic and Pulmonary Hemodynamics and Ventricular Function in Patients With Severe Symptomatic Aortic Stenosis
2012
Diagnosis and Treatment of Secondary (Non–Category 1) Pulmonary Hypertension
2008
ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension
2009 Standout
PDE5 Inhibition With Sildenafil Improves Left Ventricular Diastolic Function, Cardiac Geometry, and Clinical Status in Patients With Stable Systolic Heart Failure
2010
Hypoxia-Inducible Factor 1α Is a Critical Downstream Mediator for Hypoxia-Induced Mitogenic Factor (FIZZ1/RELMα)–Induced Pulmonary Hypertension
2015 StandoutNobel
Idiopathic Pulmonary Fibrosis
2018 Standout
Review of bosentan in the management of pulmonary arterial hypertension-0
2011
Integrating mechanisms of pulmonary fibrosis
2011 Standout
Works of Stephen C. Mathai being referenced
Right Ventricular Dysfunction in Systemic Sclerosis–Associated Pulmonary Arterial Hypertension
2013
Comparison of Moderate versus Deep Sedation for Endobronchial Ultrasound Transbronchial Needle Aspiration
2013
Interleukin-6 and Tumor Necrosis Factor-α Are Associated with Quality of Life–Related Symptoms in Pulmonary Arterial Hypertension
2015
Therapy for pulmonary arterial hypertension associated with systemic sclerosis
2009
Long-Term Outcome of Bosentan Treatment in Idiopathic Pulmonary Arterial Hypertension and Pulmonary Arterial Hypertension Associated with the Scleroderma Spectrum of Diseases
2005
Systemic sclerosis–related pulmonary hypertension associated with interstitial lung disease: Impact of pulmonary arterial hypertension therapies
2011
Erythroid-Specific Transcriptional Changes in PBMCs from Pulmonary Hypertension Patients
2012
Sleep Quality and Health-Related Quality of Life in Idiopathic Pulmonary Fibrosis
2008
Clinical differences between idiopathic and scleroderma‐related pulmonary hypertension
2006
Clinical phenotypes and survival of pre-capillary pulmonary hypertension in systemic sclerosis
2018
Pulmonary Arterial Hypertension in Connective Tissue Diseases
2012
Outcomes of hospitalisation for right heart failure in pulmonary arterial hypertension
2011
Survival in pulmonary hypertension associated with the scleroderma spectrum of diseases: Impact of interstitial lung disease
2009
Hemodynamic Predictors of Survival in Scleroderma-related Pulmonary Arterial Hypertension
2010
Identification of candidate genes in scleroderma-related pulmonary arterial hypertension
2008
Prognostic value of the pre-transplant diastolic pulmonary artery pressure–to–pulmonary capillary wedge pressure gradient in cardiac transplant recipients with pulmonary hypertension
2013
Hyponatremia Predicts Right Heart Failure and Poor Survival in Pulmonary Arterial Hypertension
2008
Clinical trial design and new therapies for pulmonary arterial hypertension
2018
Addition of sildenafil to bosentan monotherapy in pulmonary arterial hypertension
2006
The Minimal Important Difference in the 6-Minute Walk Test for Patients with Pulmonary Arterial Hypertension
2012
Tricuspid Annular Displacement Predicts Survival in Pulmonary Hypertension
2006
Ambrisentan and Tadalafil Up-front Combination Therapy in Scleroderma-associated Pulmonary Arterial Hypertension
2015
Pulmonary Effective Arterial Elastance as a Measure of Right Ventricular Afterload and Its Prognostic Value in Pulmonary Hypertension Due to Left Heart Disease
2018
60: Impact of Pre-Transplant Pulmonary Hypertension on Post-Transplant Outcomes in IPF
2010
Pulmonary hypertension and interstitial lung disease within PHAROS: impact of extent of fibrosis and pulmonary physiology on cardiac haemodynamic parameters.
2015
Pulmonary Capillary Wedge Pressure Augments Right Ventricular Pulsatile Loading
2011
PDE5A Inhibitor Treatment of Persistent Pulmonary Hypertension After Mechanical Circulatory Support
2008
Recommendations for Screening and Detection of Connective Tissue Disease–Associated Pulmonary Arterial Hypertension
2013
Right Ventricular Myofilament Functional Differences in Humans With Systemic Sclerosis–Associated Versus Idiopathic Pulmonary Arterial Hypertension
2018